| Metric | Q4 2025 | Q3 2025 | Q4 2024 | QoQ Change | YoY Change |
|---|---|---|---|---|---|
| Revenue | $903M | — | — | — | — |
| Op. Income | $187M | — | — | — | — |
| Gross Margin | 55.6% | — | — | — | — |
| Net Margin | 18.7% | — | — | — | — |
| EPS (Diluted) | $0.20 | — | — | — | — |
| Free Cash Flow | $114M | — | — | — | — |
| Item | Amount |
|---|---|
| REVENUE | $903M |
| Cost of Revenue | $401M |
| GROSS PROFIT | $502M |
| R&D Expenses | $77M |
| Selling & Marketing | $0 |
| General & Administrative | $0 |
| SG&A Expenses | $255M |
| Other Expenses | -$18M |
| Operating Expenses | $314M |
| Cost & Expenses | $716M |
| OPERATING INCOME | $187M |
| Interest Income | $6M |
| Interest Expense | $7M |
| Other Income/Expenses | $26M |
| INCOME BEFORE TAX | $213M |
| Income Tax Expense | $44M |
| Net Income from Continuing Ops | $169M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $169M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $169M |
| D&A | $48M |
| EBIT | $220M |
| EBITDA | $268M |
| EPS | $0 |
| EPS Diluted | $0 |
| Item | Amount |
|---|---|
| REVENUE | $903M |
| Cost of Revenue | $401M |
| GROSS PROFIT | $502M |
| R&D Expenses | $77M |
| Selling & Marketing | $0 |
| General & Administrative | $0 |
| SG&A Expenses | $255M |
| Other Expenses | -$18M |
| Operating Expenses | $314M |
| Cost & Expenses | $716M |
| OPERATING INCOME | $187M |
| Interest Income | $6M |
| Interest Expense | $7M |
| Other Income/Expenses | $26M |
| INCOME BEFORE TAX | $213M |
| Income Tax Expense | $44M |
| Net Income from Continuing Ops | $169M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $169M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $169M |
| D&A | $48M |
| EBIT | $220M |
| EBITDA | $268M |
| EPS | $0 |
| EPS Diluted | $0 |
| Item | Amount |
|---|---|
| Net Income | $169M |
| Depreciation & Amortization | $48M |
| Stock-Based Compensation | $1M |
| Deferred Income Tax | $44M |
| Other Non-Cash Items | -$35M |
| Change in Working Capital | $6M |
| OPERATING CASH FLOW | $234M |
| Capital Expenditure | -$119M |
| Acquisitions (Net) | -$18M |
| Purchases of Investments | -$659M |
| Sales/Maturities of Investments | $640M |
| Other Investing Activities | -$24M |
| NET CASH FROM INVESTING | -$141M |
| Net Debt Issuance | -$55M |
| Common Stock Repurchased | -$15M |
| Common Dividends Paid | $0 |
| Other Financing Activities | $66M |
| NET CASH FROM FINANCING | -$78M |
| FREE CASH FLOW | $114M |
| Net Change in Cash | $17M |
| Item | Amount |
|---|---|
| Cash & Equivalents | $156M |
| Short-Term Investments | $459M |
| Net Receivables | $1.2B |
| Inventory | $755M |
| Other Current Assets | $48M |
| TOTAL CURRENT ASSETS | $2.7B |
| PP&E (Net) | $1.0B |
| Goodwill | $125M |
| Intangible Assets | $1.0B |
| Long-Term Investments | $161M |
| Tax Assets | $197M |
| Other Non-Current Assets | $30M |
| TOTAL NON-CURRENT ASSETS | $2.6B |
| TOTAL ASSETS | $5.2B |
| Account Payables | $213M |
| Short-Term Debt | $404M |
| Deferred Revenue | $21M |
| Other Current Liabilities | $144M |
| TOTAL CURRENT LIABILITIES | $1.4B |
| Long-Term Debt | $40M |
| Deferred Revenue NC | $12M |
| Deferred Tax Liabilities | $150M |
| Other Non-Current Liabilities | $24M |
| TOTAL NON-CURRENT LIABILITIES | $270M |
| TOTAL LIABILITIES | $1.7B |
| Common Stock | $9M |
| Additional Paid-In Capital | $120M |
| Retained Earnings | $3.4B |
| Treasury Stock | -$24M |
| Accum. Other Comp. Income | $42M |
| Other Equity | $40M |
| TOTAL STOCKHOLDERS' EQUITY | $3.5B |
| Minority Interest | $40M |
| TOTAL EQUITY | $3.6B |
| TOTAL LIABILITIES & EQUITY | $5.2B |
| Total Debt | $497M |
| Net Debt | $341M |
